ArticleFrontiers in pharmacology2023

Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective cohort study (BETAPANC).

Antoine Le Bozec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.